Core Viewpoint - The company,拓新药业, is focused on research, production, and sales in the pharmaceutical and health sector, with a diversified business layout covering APIs, pharmaceutical intermediates, and functional food ingredients [1] Business Operations - The company has established a broad product line that serves key health areas such as antiviral, antitumor, and neurological medications, as well as functional foods [1] - The company’s subsidiary, 新乡制药, is producing and supplying the antiviral drug Ribavirin in a large-scale and stable manner to meet the public health demand during the flu season [1] Market Demand and Supply - Ribavirin is identified as a broad-spectrum and potent antiviral drug, serving as a key component in related antiviral medications [1] - The company has sufficient supply of APIs, which provides critical support for downstream formulation companies in producing flu treatment drugs, thereby alleviating market pressure during peak flu periods [1] Future Prospects - The company is actively pursuing the development of new antiviral drugs targeting influenza, aiming to address future market demands [1]
拓新药业：公司长期致力于医药健康领域的研发、生产与销售